Episode · RVMD · Nov 10, 10:59 AM

NOW: 2026-11-10T15:59Z

WOKE FOR: RVMD (P0 risk)

OBSERVATIONS
- 15:59Z price, P0, salience 60: RVMD, which you hold, moved -3.00% since your last review at 198.96; stop 160.43.

YOUR BOOK (the paper account: your decisions trade it; started with $10,000)
cash $3447.57 · equity $10209.45 (+2.09%) · today -0.09% · 9 stocks, 0 options positions
- MPC: 1 shares at 383.85, now 386.1 (0.59%), stop 312.05, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 148.9% (skipping the last month), 25.9% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- PSX: 2 shares at 248.78, now 247.28 (-0.54%), stop 212.58, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:01 AM ET. Thesis: Long-term leader: 12-month return 107.2% (skipping the last month), 21.7% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- PTC: 7 shares at 195.33, now 196.12 (0.40%), stop 190.75, target none, TREND CORE (rules-managed: its stop trails and a close below the 50-day average sells it; sell it yourself only on news that breaks the trend), multi_day horizon, opened 10:01 AM ET. Thesis: Trend core: 16.8% above a 50-day average 12.9% over the 200-day; 6-month 33% at 1.17% daily ATR (strength 28.2); 100% of its 52-week high Invalidation: The trailing stop, or a close below the 50-day average.
- RVMD: 2 shares at 198.96, now 192.99 (-3.11%), stop 160.43, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 217.0% (skipping the last month), 21.8% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- S: 107 shares at 23.57, now 23.42 (-0.55%), stop 22.66, target 25, multi_day horizon, opened 9:46 AM ET. Thesis: Strongest setup: price above SMA20/50/200, positive 5d return, heavy volume breakout. Opening range low 22.66 provides tight stop. Reward 6% vs risk 4% (R:R > 1.2). Invalidation: Price closes below 22.66.
- SPY: 1 shares at 747.67, now 746.945 (-0.05%), stop none, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term book: SPY at 15% of equity, held while its weekly close stays above its 200-day average: last week closed at 735.29, 0.67% vs its 200-day average 730.38. Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- U: 2 shares at 52.97, now 50.125 (-5.34%), stop 47.67, target none, TREND CORE (rules-managed: its stop trails and a close below the 50-day average sells it; sell it yourself only on news that breaks the trend), multi_day horizon, opened 10:01 AM ET. Thesis: Trend core: 21.2% above a 50-day average 34% over the 200-day; 6-month 82.8% at 5.23% daily ATR (strength 15.84); 97% of its 52-week high Invalidation: The trailing stop, or a close below the 50-day average.
- USO: 3 shares at 143.74, now 140.265 (-2.41%), stop 115.75, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 107.8% (skipping the last month), 17.8% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).
- VLO: 1 shares at 352.24, now 346.18 (-1.74%), stop 300.25, target none, LONG-TERM BOOK (rules-managed: held for months until a week closes below its 200-day average; sell it yourself only on news that breaks the long-term case), multi_day horizon, opened 10:00 AM ET. Thesis: Long-term leader: 12-month return 160.8% (skipping the last month), 19.4% above its 200-day average Invalidation: A week closing below its 200-day average (a leader also: its trailing stop, or dropping out of the top at a month's refresh).

LIMITS (enforced by code)
- Market: the regular session. New buys: allowed.
- Your envelope: 2/8 entries in 24 h, 0/3 in the last hour, 1/4 open; one action per ticker per 30 min; no re-entry for 6 h after a stop-out or 2 h after an exit.
- Sizing is code's: a buy risks 1% of equity at its stop (×0.75 at conviction 6, up to ×1.25 at 10), up to 25% of equity per position ($2552.36). A closer stop means more shares; leave allocation_pct null.
- Risk checks: 3/8 positions; conviction ≥ 6/10 (no intraday buys in the closing window); price ≥ $5; stop 0.4-10% below the price (default 2.5%); reward:risk ≥ 1.2; no rebuy within 15 min of a sale; $3243.38 deployable cash.
- Options: open premium $0 of the 25% of equity cap ($2552); at most 4% of equity per position; 0/6 positions; conviction ≥ 7; long calls and puts, call and put debit spreads; buy |delta| 0.25-0.7, 7-45 days to expiration; contracts only from an option_menu result in this episode; exits default to -60% / +150% of the position's value, and code closes positions before expiration.
- Intraday stock positions are closed by code in the last minutes of the session; overnight and multi-day ones stay. Stops and targets rest at the broker as bracket or OCO orders, and once a position is up by its stop distance code trails its stop at that distance behind the price.

MARKET
- SPY 746.945 (-0.77%), QQQ 672.3 (-0.95%), IWM 278.75, DIA 520.33, VIXY 18.83, TLT 80.87

SUBJECT RVMD
- 192.99 (bid 192.75, ask 194.18), -3.63% today; technicals: use the tools
- news in our feeds, last 24 h, most severe first:
<untrusted source="wire">
d28830b00c6f [Nov 10, 1:00 AM ET | T2 marketbeat.com | earnings | sev 79 | +1 confirmations] What Revolution Medicines (RVMD) Said on Its Q3 Earnings Call (https://www.marketbeat.com/instant-alerts/transcript-what-revolution-medicines-rvmd-said-on-its-q3-earnings-call-2026-11-05?.tsrc=rss)
a53e465e4c2a [Nov 10, 7:44 AM ET | T2 finnhub.io | earnings | sev 71] Revolution Medicines, Inc. 2026 Q3 - Results - Earnings Call Presentation (https://finnhub.io/api/news?id=f68a9a64c4306c4274a8481856f30ef0268ddb348c24164213ffc090b8b1f720)
1e660e063ad1 [Nov 10, 1:02 AM ET | T2 nasdaq.com | earnings | sev 71] RVMD Q3 Earnings & Sales Beat Estimates on Encouraging Rasonque Uptake (https://www.nasdaq.com/articles/rvmd-q3-earnings-sales-beat-estimates-encouraging-rasonque-uptake)
</untrusted>

YOUR NOTES
- [MARKET, 2026-11-10T15:48Z] Closing window active (15:48Z). No new entries allowed. All observed setups (UTHR, IYW, LABD, NVDQ, NVD, TEL, DXD, ALL, CMG, SPXS) are late-day breakouts without confirmed catalysts (news absent or unconfirmed anomalies). Book holds 9 stocks; no exits triggered. Cash $3447.57.
- [MARKET, 2026-11-10T15:43Z] Closing window (17:00-18:00 ET) is active. No new entries allowed. All observed setups (SGOL, NVDQ, GPN, LYV, CLX, FICO, UCO, CSCO, TZA, SECZ, JBHT, TPL, MCK, RWM, STZ, CME) are late-day breakouts without confirmed catalysts (news absent or unconfirmed anomalies). Book holds 9 stocks; no exits triggered. Cash $3447.57.
- [MARKET, 2026-11-10T15:18Z] Closing window (17:00-18:00 ET) is active. No new entries allowed. All observed setups (AGQ, A… [cut: 8,886 characters in all]

{
  "decisions": [],
  "watches": [],
  "cancel_watches": [],
  "notes": [],
  "reply": "RVMD is down 3.6% today despite Q3 earnings beating estimates and encouraging Rasonque uptake. The move lacks a specific negative catalyst and appears to be a post-earnings profit-taking or sector-wide pullback. The long-term thesis (12-month return 217%, 21.8% above 200-day average) remains intact, and the stop at 160.43 is wide enough to absorb this volatility. No action taken."
}